What is the recommended loading dose of digoxin (Digitalis glycoside) for a patient with impaired renal function, specifically a Glomerular Filtration Rate (GFR) of 40?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For patients with impaired renal function and a GFR of 40 mL/min, the recommended loading dose of digoxin is 0.25-0.5 mg IV bolus, which can be repeated up to a maximum dose of 1.0 mg over 24 h (ie, maximum loading dose 8–12 mcg/kg), given at 6–8-h intervals. This dose can be adjusted based on the patient's age, lean body weight, renal function, and concomitant drugs. The maintenance dose should be reduced to account for decreased renal clearance, usually 0.125-0.25 mg daily or every other day, with careful monitoring of serum digoxin levels 1. Dose adjustments are necessary because digoxin is primarily eliminated by the kidneys, and renal impairment leads to drug accumulation and increased risk of toxicity. Before initiating therapy, baseline serum potassium, magnesium, calcium, and renal function should be assessed, as electrolyte abnormalities can potentiate digoxin toxicity. Regular monitoring of digoxin serum levels (therapeutic range 0.8-2.0 ng/mL) is essential, particularly in patients with renal impairment, to prevent toxicity while maintaining efficacy. Some key points to consider when using digoxin in patients with renal impairment include:

  • Reduce dose based on plasma concentrations 1
  • Monitor serum digoxin levels closely to avoid toxicity
  • Be aware of potential interactions with other medications, such as amiodarone, dronedarone, and verapamil, which can increase serum digoxin concentrations 1
  • Consider alternative medications or dose adjustments in patients with severe renal impairment (GFR < 30 mL/min) 1.

From the FDA Drug Label

Peak digoxin body stores of 8 to 12 mcg/kg should provide therapeutic effect with minimum risk of toxicity in most patients with heart failure and normal sinus rhythm. Because of altered digoxin distribution and elimination, projected peak body stores for patients with renal insufficiency should be conservative (i.e., 6 to 10 mcg/kg) The usual amount of digoxin tablets that a 70 kg patient requires to achieve 8 to 12 mcg/kg peak body stores is 750 to 1250 mcg (0.75 to 1. 25 mg). A single initial dose of 500 to 750 mcg (0.5 to 0.75 mg) of digoxin tablets usually produces a detectable effect in 0.5 to 2 hours that becomes maximal in 2 to 6 hours. Additional doses of 125 to 375 mcg (0. 125 to 0.375 mg) may be given cautiously at 6 to 8-hour intervals until clinical evidence of an adequate effect is noted.

For a patient with a Glomerular Filtration Rate (GFR) of 40, which indicates impaired renal function, a conservative approach to loading dose is recommended.

  • The projected peak body stores for patients with renal insufficiency should be 6 to 10 mcg/kg.
  • For a 70 kg patient, the loading dose can be calculated as follows:
  • 6 mcg/kg x 70 kg = 420 mcg
  • 10 mcg/kg x 70 kg = 700 mcg
  • Therefore, the recommended loading dose of digoxin for a patient with a GFR of 40 is between 420 mcg and 700 mcg, administered in several portions, with careful assessment of clinical response before each additional dose 2.

From the Research

Digoxin Loading Dose for Impaired Renal Function

The recommended loading dose of digoxin for a patient with impaired renal function, specifically a Glomerular Filtration Rate (GFR) of 40, is not directly stated in the provided studies. However, we can consider the following points:

  • The study 3 suggests that renal dysfunction is strongly associated with mortality in stable outpatients with heart failure, notably in patients with estimated GFR <50 ml/min per 1.73 m(2).
  • The study 4 found that patients on digoxin throughout had a significantly greater rate of decline in eGFR per year than patients not on digoxin throughout.
  • The study 5 discusses the importance of estimating renal function for drug dosing decisions, but does not provide specific guidance on digoxin loading doses.
  • The study 6 assesses the potential effects of digoxin on renal function in patients diagnosed with CHF, but does not provide information on loading doses.
  • The study 7 evaluates the agreement between estimating and gold standard methods to assess glomerular filtration rate (GFR) in critically ill patients with acute kidney injury, but does not provide guidance on digoxin loading doses.

Key Considerations

  • When estimating renal function, it is essential to consider the limitations of commonly used methods, such as urinary creatinine clearance and estimating equations 7.
  • The effect of digoxin on renal function may vary depending on the level of renal impairment 3, 4.
  • The loading dose of digoxin may need to be adjusted based on the patient's renal function, but the exact adjustment is not specified in the provided studies.

Potential Loading Dose Considerations

  • For patients with a GFR of 40, the loading dose of digoxin may need to be reduced to avoid toxicity, but the exact reduction is not specified in the provided studies.
  • The study 3 suggests that digoxin efficacy did not differ by level of GFR, but this does not provide guidance on loading doses.
  • The study 4 found that the rate of decline in renal function is greater in patients with CHF who are taking digoxin, which may impact the loading dose.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.